Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Patankar

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Human Reproduction|October 1, 1996
Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-AH Koistinen, R Koistinen, A Dell, et al.
The Journal of Biological Chemistry|December 13, 1996
Gender-specific glycosylation of human glycodelin affects its contraceptive activityH R Morris, A Dell, R L Easton, et al.
Nuclear Medicine and Biology|July 25, 2023
Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancerS L V Hoffman, J C Mixdorf, O Kwon, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Human Reproduction|October 1, 1996
Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-AH Koistinen, R Koistinen, A Dell, et al.
The Journal of Biological Chemistry|December 13, 1996
Gender-specific glycosylation of human glycodelin affects its contraceptive activityH R Morris, A Dell, R L Easton, et al.
Nuclear Medicine and Biology|July 25, 2023
Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancerS L V Hoffman, J C Mixdorf, O Kwon, et al.
Pageof 2